Shandong Pharmaceutical Glass Co (SHSE:600529) Piotroski F-Score: 5 (As of Jul. 05, 2026) — 17% Below Median


SHSE:600529 Shandong Pharmaceutical Glass Co Ltd SHSE:600529
89 GF Score
Price ¥18.66
GF Value ¥24.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shandong Pharmaceutical Glass Co Piotroski F-Score?

Shandong Pharmaceutical Glass Co SHSE:600529 +1.19% 89 Piotroski F-Score is 5 as of Jul. 05, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates SHSE:600529 with a GF Score™ of 89/100 and a GF Value™ of ¥24.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 388 Packaging & Containers companies, Shandong Pharmaceutical Glass Co ranks better than 54.64% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shandong Pharmaceutical Glass Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shandong Pharmaceutical Glass Co's Piotroski F-Score or its related term are showing as below:

SHSE:600529' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Shandong Pharmaceutical Glass Co was 9. The lowest was 4. And the median was 6.

Shandong Pharmaceutical Glass Co  (SHSE:600529) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shandong Pharmaceutical Glass Co Piotroski F-Score Related Terms


Shandong Pharmaceutical Glass Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shandong Pharmaceutical Glass Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Pharmaceutical Glass Co Piotroski F-Score Chart

Shandong Pharmaceutical Glass Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 4.00 6.00 6.00 5.00

Shandong Pharmaceutical Glass Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 6.00 5.00 5.00 5.00

SHSE:600529 vs SW, PKG, IP: Piotroski F-Score Comparison

For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Pharmaceutical Glass Co Piotroski F-Score vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shandong Pharmaceutical Glass Co's Piotroski F-Score falls into.


SHSE:600529
89GF Score
Shandong Pharmaceutical Glass Co Ltd SHSE:600529
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 147.512 + 171.312 + 147.172 + 201.206 = ¥667 Mil.
Cash Flow from Operations was 208.908 + 211.516 + 65.968 + 212.989 = ¥699 Mil.
Revenue was 1079.024 + 1101.861 + 1121.949 + 1219.064 = ¥4,522 Mil.
Gross Profit was 375.652 + 373.898 + 365.445 + 396.963 = ¥1,512 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(10173.366 + 9975.463 + 9882.355 + 10043.77 + 10136.628) / 5 = ¥10042.3164 Mil.
Total Assets at the begining of this year (Mar25) was ¥10,173 Mil.
Long-Term Debt & Capital Lease Obligation was ¥27 Mil.
Total Current Assets was ¥6,107 Mil.
Total Current Liabilities was ¥1,612 Mil.
Net Income was 254.377 + 245.265 + 222.56 + 223.629 = ¥946 Mil.

Revenue was 1264.64 + 1171.965 + 1241.019 + 1171.185 = ¥4,849 Mil.
Gross Profit was 448.908 + 391.262 + 398.101 + 375.289 = ¥1,614 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(9588.071 + 9891.173 + 9979.008 + 10140.009 + 10173.366) / 5 = ¥9954.3254 Mil.
Total Assets at the begining of last year (Mar24) was ¥9,588 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0 Mil.
Total Current Assets was ¥6,055 Mil.
Total Current Liabilities was ¥1,814 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shandong Pharmaceutical Glass Co's current Net Income (TTM) was 667. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shandong Pharmaceutical Glass Co's current Cash Flow from Operations (TTM) was 699. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=667.202/10173.366
=0.06558321

ROA (Last Year)=Net Income/Total Assets (Mar24)
=945.831/9588.071
=0.09864664

Shandong Pharmaceutical Glass Co's return on assets of this year was 0.06558321. Shandong Pharmaceutical Glass Co's return on assets of last year was 0.09864664. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shandong Pharmaceutical Glass Co's current Net Income (TTM) was 667. Shandong Pharmaceutical Glass Co's current Cash Flow from Operations (TTM) was 699. ==> 699 > 667 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=26.922/10042.3164
=0.00268086

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/9954.3254
=0

Shandong Pharmaceutical Glass Co's gearing of this year was 0.00268086. Shandong Pharmaceutical Glass Co's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=6106.79/1611.973
=3.78839472

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=6054.844/1813.629
=3.33852403

Shandong Pharmaceutical Glass Co's current ratio of this year was 3.78839472. Shandong Pharmaceutical Glass Co's current ratio of last year was 3.33852403. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shandong Pharmaceutical Glass Co's number of shares in issue this year was 670.687. Shandong Pharmaceutical Glass Co's number of shares in issue last year was 657.734. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1511.958/4521.898
=0.33436358

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1613.56/4848.809
=0.3327745

Shandong Pharmaceutical Glass Co's gross margin of this year was 0.33436358. Shandong Pharmaceutical Glass Co's gross margin of last year was 0.3327745. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=4521.898/10173.366
=0.44448396

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=4848.809/9588.071
=0.50571267

Shandong Pharmaceutical Glass Co's asset turnover of this year was 0.44448396. Shandong Pharmaceutical Glass Co's asset turnover of last year was 0.50571267. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shandong Pharmaceutical Glass Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Piotroski F-Score of 5 as of Jul. 05, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Shandong Pharmaceutical Glass Co's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #176 out of 388 companies in the Packaging & Containers industry, placing it in the top 45.4%.
Is Shandong Pharmaceutical Glass Co's Piotroski F-Score too high?
Shandong Pharmaceutical Glass Co's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Packaging & Containers industry median Piotroski F-Score is 5.00. Shandong Pharmaceutical Glass Co's value of 5 is 0% at this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #176 out of 388 companies in the Packaging & Containers industry, which is above the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Piotroski F-Score compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #176 out of 388 companies for Piotroski F-Score. This puts Shandong Pharmaceutical Glass Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Shandong Pharmaceutical Glass Co's value of 5 is 0% at this benchmark. Historically, Shandong Pharmaceutical Glass Co's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Shandong Pharmaceutical Glass Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Packaging & Containers company?
The median Piotroski F-Score among Packaging & Containers companies is 5.00, based on 388 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.08, compared to a current price of ¥18.66 — trading 22.5% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Packaging & Containers industry median of 5.00. Shandong Pharmaceutical Glass Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Piotroski F-Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued. The current stock price of ¥18.66 is trading 22.5% below its estimated GF Value™ of ¥24.08. GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.

Key valuation signals for SHSE:600529:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: ¥24.08 vs. price of ¥18.66 (22.5% below fair value)
  • GF Score™: 89/100 with 4 warning signs
  • Industry Position: 0% at the Packaging & Containers median (#176 of 388)

No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Pharmaceutical Glass Co Business Description

Address Yaobo Road, Yiyuan County, Zibo, Shandong, CHN, 256100
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
89GF Score

Get the complete analysis for SHSE:600529

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.66
Price
¥24.08
GF Value